HEADER HYDROLASE/HYDROLASE INHIBITOR 01-NOV-04 1WBG TITLE ACTIVE SITE THROMBIN INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: THROMBIN LIGHT CHAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: FRAGMENT ALPHA THROMBIN, RESIDUES 328-363; COMPND 5 SYNONYM: THROMBIN, COAGULATION FACTOR II; COMPND 6 EC: 3.4.21.5; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: THROMBIN HEAVY CHAIN; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: FRAGMENT ALPHA THROMBIN, RESIDUES 364-622; COMPND 11 SYNONYM: THROMBIN, COAGULATION FACTOR II; COMPND 12 EC: 3.4.21.5; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: HIRUGEN; COMPND 15 CHAIN: I; COMPND 16 FRAGMENT: PEPTIDE FRAGMENT OF HIRUGEN, RESIDUES 62-71; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: BLOOD PLASMA; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 TISSUE: BLOOD PLASMA; SOURCE 11 MOL_ID: 3; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: HIRUDO MEDICINALIS; SOURCE 14 ORGANISM_COMMON: MEDICINAL LEECH; SOURCE 15 ORGANISM_TAXID: 6421 KEYWDS BLOOD COAGULATION-INHIBITOR, SERINE PROTEASE, BLOOD COAGULATION, KEYWDS 2 ACUTE PHASE, CALCIUM-BINDING, DISEASE MUTATION, GAMMA- KEYWDS 3 CARBOXYGLUTAMIC ACID, GLYCOPROTEIN, KRINGLE, POLYMORPHISME, VITAMIN KEYWDS 4 K, ZYMOGEN, SULFATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.J.HARTSHORN,C.W.MURRAY,A.CLEASBY,M.FREDERICKSON,I.J.TICKLE,H.JHOTI REVDAT 5 28-JUN-17 1WBG 1 REMARK REVDAT 4 13-JUL-11 1WBG 1 VERSN REVDAT 3 24-FEB-09 1WBG 1 VERSN REVDAT 2 01-DEC-05 1WBG 1 REMARK REVDAT 1 27-JAN-05 1WBG 0 JRNL AUTH M.J.HARTSHORN,C.W.MURRAY,A.CLEASBY,M.FREDERICKSON, JRNL AUTH 2 I.J.TICKLE,H.JHOTI JRNL TITL FRAGMENT-BASED LEAD DISCOVERY USING X-RAY CRYSTALLOGRAPHY JRNL REF J.MED.CHEM. V. 48 403 2005 JRNL REFN ISSN 0022-2623 JRNL PMID 15658854 JRNL DOI 10.1021/JM0495778 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.21 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 16409 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.171 REMARK 3 R VALUE (WORKING SET) : 0.166 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 876 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1169 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.1860 REMARK 3 BIN FREE R VALUE SET COUNT : 65 REMARK 3 BIN FREE R VALUE : 0.3560 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2369 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 388 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.22000 REMARK 3 B22 (A**2) : -1.47000 REMARK 3 B33 (A**2) : 0.11000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.38000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.272 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.247 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.154 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.980 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.895 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2452 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2193 ; 0.004 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3308 ; 1.430 ; 1.966 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5109 ; 0.808 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 287 ; 6.863 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 118 ;34.616 ;23.729 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 431 ;13.831 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;18.186 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 337 ; 0.089 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2682 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 500 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 501 ; 0.213 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2343 ; 0.187 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1160 ; 0.180 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1352 ; 0.085 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 108 ; 0.144 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 7 ; 0.150 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 51 ; 0.275 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 8 ; 0.104 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1880 ; 3.200 ; 5.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2339 ; 3.719 ; 6.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1210 ; 3.495 ; 6.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 969 ; 4.498 ; 7.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. DISORDER AT TWO-FOLD; ARG B 75 CLASHES. THE OCCUPANCY REMARK 3 OF SIDE CHAIN ATOMS WAS SET TO 0 FOR REFINEMENT. THESE ATOMS REMARK 3 REMOVED FOR DURING PDB ANNOTATION. REMARK 4 REMARK 4 1WBG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-NOV-04. REMARK 100 THE DEPOSITION ID IS D_1290021491. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-DEC-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : CONFOCAL MULTILAYER REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17712 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 27.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 2.040 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.4 REMARK 200 DATA REDUNDANCY IN SHELL : 1.85 REMARK 200 R MERGE FOR SHELL (I) : 0.23000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: IN-HOUSE SOFTWARE REMARK 200 STARTING MODEL: PDB ENTRY 1QJ1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 34.69600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.89250 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 34.69600 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.89250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B2144 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 FUNCTION: THROMBIN, WHICH CLEAVES BONDS AFTER ARG AND LYS, REMARK 400 CONVERTS FIBRINOGEN TO FIBRIN AND ACTIVATES FACTORS V, VII, VIII, REMARK 400 XIII, AND, IN COMPLEX WITH THROMBOMODULIN, PROTEIN C. REMARK 400 CATALYTIC ACTIVITY: PREFERENTIAL CLEAVAGE: ARG-|-GLY; ACTIVATES REMARK 400 FIBRINOGEN TO FIBRIN AND RELEASES FIBRINOPEPTIDE A AND B. REMARK 400 SUBCELLULAR LOCATION: EXTRACELLULAR. REMARK 400 TISSUE SPECIFICITY: EXPRESSED BY THE LIVER AND SECRETED IN PLASMA. REMARK 400 DISEASE: DEFECTS IN F2 ARE THE CAUSE OF VARIOUS FORMS OF REMARK 400 DYSPROTHROMBINEMIA [MIM:176930]. REMARK 400 SIMILARITY: BELONGS TO THE PEPTIDASE S1 FAMILY. REMARK 400 SIMILARITY: CONTAINS 1 GAMMA-CARBOXY-GLUTAMATE DOMAIN (GLA) REMARK 400 DOMAIN. REMARK 400 SIMILARITY: CONTAINS 2 KRINGLE DOMAINS. REMARK 400 REMARK 400 FUNCTION: HIRUDIN IS A POTENT THROMBIN-SPECIFIC PROTEASE REMARK 400 INHIBITOR. IT FORMS A STABLE NON-COVALENT COMPLEX WITH ALPHA- REMARK 400 THROMBIN, THEREBY ABOLISHING ITS ABILITY TO CLEAVE FIBRINOGEN. REMARK 400 SUBCELLULAR LOCATION: SECRETED. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A -3 REMARK 465 PHE A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 THR B 147 REMARK 465 TRP B 148 REMARK 465 THR B 149E REMARK 465 ALA B 149D REMARK 465 ASN B 149C REMARK 465 VAL B 149B REMARK 465 GLY B 149A REMARK 465 LYS B 149 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 15 CA C O CB CG CD NE REMARK 470 ARG A 15 CZ NH1 NH2 REMARK 470 ARG B 75 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 C CYS B 220 N ASP B 221A 1.32 REMARK 500 C ARG B 221 N ASP B 222 1.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 2244 O HOH B 2283 4546 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU B 217 C GLY B 219 N 0.236 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU B 217 O - C - N ANGL. DEV. = -13.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 7 -87.43 -132.05 REMARK 500 ASP A 14L 72.14 -11.38 REMARK 500 ASN B 60G 71.64 -159.66 REMARK 500 HIS B 71 -58.94 -127.57 REMARK 500 ASN B 78 -7.10 71.60 REMARK 500 GLU B 97A -73.91 -111.48 REMARK 500 GLU I 58 114.80 -28.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ILE A 14K ASP A 14L -149.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLU B 217 22.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2015 DISTANCE = 6.57 ANGSTROMS REMARK 525 HOH A2018 DISTANCE = 6.96 ANGSTROMS REMARK 525 HOH B2002 DISTANCE = 5.91 ANGSTROMS REMARK 525 HOH B2008 DISTANCE = 6.36 ANGSTROMS REMARK 525 HOH B2017 DISTANCE = 6.71 ANGSTROMS REMARK 525 HOH B2082 DISTANCE = 5.90 ANGSTROMS REMARK 525 HOH B2090 DISTANCE = 5.90 ANGSTROMS REMARK 525 HOH B2092 DISTANCE = 6.45 ANGSTROMS REMARK 525 HOH B2097 DISTANCE = 5.97 ANGSTROMS REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "BB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L03 B 1248 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS B 1249 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS B 1250 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS B 1251 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN I OF HIRUGEN REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A2C RELATED DB: PDB REMARK 900 STRUCTURE OF THROMBIN INHIBITED BY AERUGINOSIN298-A FROM A BLUE- REMARK 900 GREEN ALGA REMARK 900 RELATED ID: 1A3B RELATED DB: PDB REMARK 900 COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL BORONATE REMARK 900 INHIBITOR BOROLOG1 REMARK 900 RELATED ID: 1A3E RELATED DB: PDB REMARK 900 COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL BORONATE REMARK 900 INHIBITOR BOROLOG2 REMARK 900 RELATED ID: 1A46 RELATED DB: PDB REMARK 900 THROMBIN COMPLEXED WITH HIRUGEN AND A BETA- STRAND MIMETIC INHIBITOR REMARK 900 RELATED ID: 1A4W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF THROMBIN WITH THIAZOLE- CONTAINING INHIBITORS: REMARK 900 PROBES OF THE S1' BINDING SITE REMARK 900 RELATED ID: 1A5G RELATED DB: PDB REMARK 900 HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC REMARK 900 INHIBITOR AND HIRUGEN REMARK 900 RELATED ID: 1A61 RELATED DB: PDB REMARK 900 THROMBIN COMPLEXED WITH A BETA-MIMETIC THIAZOLE-CONTAINING INHIBITOR REMARK 900 RELATED ID: 1ABI RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRULOG 3 REMARK 900 RELATED ID: 1ABJ RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE (PPACK) REMARK 900 WITH CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP REMARK 900 RELATED ID: 1AD8 RELATED DB: PDB REMARK 900 COMPLEX OF THROMBIN WITH AND INHIBITOR CONTAINING A NOVEL P1 MOIETY REMARK 900 RELATED ID: 1AE8 RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN INHIBITION BY EOC-D- PHE-PRO-AZALYS-ONP REMARK 900 RELATED ID: 1AFE RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN INHIBITION BY CBZ-PRO- AZALYS-ONP REMARK 900 RELATED ID: 1AHT RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: ALPHA-THROMBIN; CHAIN: L, H; EC: 3.4.21.5; MOL_ REMARK 900 ID: 2; MOLECULE: HIRUGEN; CHAIN: I; HETEROGEN: P- AMIDINO-PHENYL- REMARK 900 PYRUVATE REMARK 900 RELATED ID: 1AI8 RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN TERNARY COMPLEX WITH THE EXOSITE INHIBITOR REMARK 900 HIRUGEN AND ACTIVE SITE INHIBITOR PHCH2OCO-D-DPA- PRO-BOROMPG REMARK 900 RELATED ID: 1AIX RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN TERNARY COMPLEX WITH EXOSITE INHIBITOR HIRUGEN REMARK 900 AND ACTIVE SITE INHIBITOR PHCH2OCO-D-DPA-PRO-BOROVAL REMARK 900 RELATED ID: 1AWF RELATED DB: PDB REMARK 900 NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT REMARK 900 RELATED ID: 1AWH RELATED DB: PDB REMARK 900 NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT REMARK 900 RELATED ID: 1AY6 RELATED DB: PDB REMARK 900 THROMBIN INHIBITOR FROM THEONALLA, CYCLOTHEANAMIDE-BASED REMARK 900 MACROCYCLIC TRIPEPTIDE MOTIF REMARK 900 RELATED ID: 1B5G RELATED DB: PDB REMARK 900 HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC REMARK 900 INHIBITOR AND HIRUGEN REMARK 900 RELATED ID: 1B7X RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN ALPHA-THROMBIN Y225I MUTANT BOUND TO D- PHE-PRO- REMARK 900 ARG- CHLOROMETHYLKETONE REMARK 900 RELATED ID: 1BA8 RELATED DB: PDB REMARK 900 THROMBIN INHIBITOR WITH A RIGID TRIPEPTIDYL ALDEHYDES REMARK 900 RELATED ID: 1BB0 RELATED DB: PDB REMARK 900 THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES REMARK 900 RELATED ID: 1BCU RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND PROFLAVIN REMARK 900 RELATED ID: 1BHX RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF THE COMPLEX OF HUMAN ALPHA THROMBIN WITH THE REMARK 900 INHIBITOR SDZ 229- 357 REMARK 900 RELATED ID: 1BMM RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH [S-(R, R)]-4- REMARK 900 [(AMINOIMINOMETHYL)AMINO]-N-[[1-[3- HYDROXY-2-[(2- REMARK 900 NAPHTHALENYLSULFONYL)AMINO]-1- OXOPROPYL]-2-PYRROLIDINYL] METHYL] REMARK 900 BUTANAMIDE (BMS-186282) REMARK 900 RELATED ID: 1BMN RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH [S-(R, R)]-1- (AMINOIMINOMETHYL) REMARK 900 -N-[[1-[N-[(2- NAPHTHALENYLSULFONYL)-L- SERYL]-PYRROLIDINYL] METHYL] REMARK 900 -3-PIPERIDENECARBOXAMIDE (BMS- 189090) REMARK 900 RELATED ID: 1BTH RELATED DB: PDB REMARK 900 STRUCTURE OF THROMBIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1C1U RELATED DB: PDB REMARK 900 RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE REMARK 900 PROTEASES REMARK 900 RELATED ID: 1C1V RELATED DB: PDB REMARK 900 RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE REMARK 900 PROTEASES REMARK 900 RELATED ID: 1C1W RELATED DB: PDB REMARK 900 RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE REMARK 900 PROTEASES REMARK 900 RELATED ID: 1C4U RELATED DB: PDB REMARK 900 SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL REMARK 900 MOIETIES. REMARK 900 RELATED ID: 1C4V RELATED DB: PDB REMARK 900 SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL REMARK 900 MOIETIES. REMARK 900 RELATED ID: 1C4Y RELATED DB: PDB REMARK 900 SELECTIVE NON-ELECTROPHILIC THROMBIN INHIBITORS REMARK 900 RELATED ID: 1C5L RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, REMARK 900 SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR REMARK 900 RELATED ID: 1C5N RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, REMARK 900 SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR REMARK 900 RELATED ID: 1C5O RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, REMARK 900 SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR REMARK 900 RELATED ID: 1CA8 RELATED DB: PDB REMARK 900 THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES REMARK 900 RELATED ID: 1D3D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH REMARK 900 BENZOTHIOPHENE INHIBITOR 4 REMARK 900 RELATED ID: 1D3P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN APLHA-THROMBIN IN COMPLEX WITH BENZO[B] REMARK 900 THIOPHENE INHIBITOR 3 REMARK 900 RELATED ID: 1D3Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZO[B] REMARK 900 THIOPHENE INHIBITOR 2 REMARK 900 RELATED ID: 1D3T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZO[B] REMARK 900 THIOPHENE INHIBITOR 1 REMARK 900 RELATED ID: 1D4P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH 5- REMARK 900 AMIDINOINDOLE-4- BENZYLPIPERIDINE INHIBITOR REMARK 900 RELATED ID: 1D6W RELATED DB: PDB REMARK 900 STRUCTURE OF THROMBIN COMPLEXED WITH SELECTIVE NON- ELECTROPHILIC REMARK 900 INHIBITORS HAVING CYCLOHEXYL MOIETIES AT P1 REMARK 900 RELATED ID: 1D9I RELATED DB: PDB REMARK 900 STRUCTURE OF THROMBIN COMPLEXED WITH SELECTIVE NON- ELECTOPHILIC REMARK 900 INHIBITORS HAVING CYCLOHEXYL MOIETIES AT P1 REMARK 900 RELATED ID: 1DE7 RELATED DB: PDB REMARK 900 INTERACTION OF FACTOR XIII ACTIVATION PEPTIDE WITH ALPHA- THROMBIN: REMARK 900 CRYSTAL STRUCTURE OF THE ENZYME-SUBSTRATE COMPLEX REMARK 900 RELATED ID: 1DIT RELATED DB: PDB REMARK 900 COMPLEX OF A DIVALENT INHIBITOR WITH THROMBIN REMARK 900 RELATED ID: 1DM4 RELATED DB: PDB REMARK 900 SER195ALA MUTANT OF HUMAN THROMBIN COMPLEXED WITH FIBRINOPEPTIDE A REMARK 900 (7-16) REMARK 900 RELATED ID: 1DOJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN* RWJ-51438 COMPLEXAT 1.7 A REMARK 900 RELATED ID: 1DWB RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH (DES-AMINO ASP 55) HIRUDIN (RESIDUES 55 REMARK 900 - 65) AND BENZAMIDINE REMARK 900 RELATED ID: 1DWC RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH (DES-AMINO ASP 55) HIRUDIN (RESIDUES 55 REMARK 900 - 65) AND MD-805 (ARGATROBAN) REMARK 900 RELATED ID: 1DWD RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH (DES-AMINO ASP 55) HIRUDIN (RESIDUES 55 REMARK 900 - 65) AND NAPAP REMARK 900 RELATED ID: 1DWE RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH (DES-AMINO ASP 55) HIRUDIN (RESIDUES 55 REMARK 900 - 65) AND D-PHE- PRO-ARG-CHLOROMETHYLKETONE (PPACK) WITH REMARK 900 CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP REMARK 900 RELATED ID: 1DX5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE THROMBIN- THROMBOMODULIN COMPLEX REMARK 900 RELATED ID: 1E0F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN ALPHA- THROMBIN-HAEMADIN COMPLEX: AN REMARK 900 EXOSITE II- BINDING INHIBITOR REMARK 900 RELATED ID: 1EB1 RELATED DB: PDB REMARK 900 COMPLEX STRUCTURE OF HUMAN THROMBIN WITH N- METHYL-ARGININE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1EOJ RELATED DB: PDB REMARK 900 DESIGN OF P1' AND P3' RESIDUES OF TRIVALENT THROMBIN INHIBITORS AND REMARK 900 THEIR CRYSTAL STRUCTURES REMARK 900 RELATED ID: 1EOL RELATED DB: PDB REMARK 900 DESIGN OF P1' AND P3' RESIDUES OF TRIVALENT THROMBIN INHIBITORS AND REMARK 900 THEIR CRYSTAL STRUCTURES REMARK 900 RELATED ID: 1FPC RELATED DB: PDB REMARK 900 ALPHA-THROMBIN TERNARY COMPLEX WITH EXOSITE INHIBITOR HIRUGEN AND REMARK 900 ACTIVE SITE INHIBITOR DANSYLARGININE N-(3-ETHYL -1,5-PENTANEDIYL) REMARK 900 AMIDE (DAPA) REMARK 900 RELATED ID: 1FPH RELATED DB: PDB REMARK 900 ALPHA-THROMBIN TERNARY COMPLEX WITH HIRUDIN AND FIBRINOPEPTIDE A REMARK 900 RELATED ID: 1G30 RELATED DB: PDB REMARK 900 THROMBIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 1G32 RELATED DB: PDB REMARK 900 THROMBIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 1G37 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITHBCH -10556 REMARK 900 AND EXOSITE-DIRECTED PEPTIDE REMARK 900 RELATED ID: 1GHV RELATED DB: PDB REMARK 900 A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- REMARK 900 CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE REMARK 900 RELATED ID: 1GHW RELATED DB: PDB REMARK 900 A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- REMARK 900 CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE REMARK 900 RELATED ID: 1GHX RELATED DB: PDB REMARK 900 A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- REMARK 900 CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE REMARK 900 RELATED ID: 1GHY RELATED DB: PDB REMARK 900 A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- REMARK 900 CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE REMARK 900 RELATED ID: 1GJ4 RELATED DB: PDB REMARK 900 SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA,SER190/ALA190 REMARK 900 PROTEASE, STRUCTURE-BASED DRUG DESIGN REMARK 900 RELATED ID: 1GJ5 RELATED DB: PDB REMARK 900 SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA,SER190/ALA190 REMARK 900 PROTEASE, STRUCTURE-BASED DRUG DESIGN REMARK 900 RELATED ID: 1H8D RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF THE HUMAN ALPHA- THROMBIN COMPLEX WITH A REMARK 900 TRIPEPTIDE PHOSPHONATE INHIBITOR. REMARK 900 RELATED ID: 1H8I RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HUMAN ALPHA- THROMBIN WITH A TRIPEPTIDE REMARK 900 PHOSPHONATE INHIBITOR. REMARK 900 RELATED ID: 1HAG RELATED DB: PDB REMARK 900 PRETHROMBIN2 COMPLEXED WITH HIRUGEN (N- ACETYLHIRUDIN 53 - 64 WITH REMARK 900 SULFATO-TYR 63) REMARK 900 RELATED ID: 1HAH RELATED DB: PDB REMARK 900 ALPHA THROMBIN COMPLEXED WITH HIRUGEN (N- ACETYLHIRUDIN 53 - 64 REMARK 900 WITH SULFATO-TYR 63) REMARK 900 RELATED ID: 1HAI RELATED DB: PDB REMARK 900 ALPHA THROMBIN COMPLEXED WITH D-PHE-PRO- ARG- CHLOROMETHYLKETONE REMARK 900 (PPACK) WITH CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP REMARK 900 RELATED ID: 1HAO RELATED DB: PDB REMARK 900 COMPLEX OF HUMAN ALPHA-THROMBIN WITH A 15MER OLIGONUCLEOTIDE REMARK 900 GGTTGGTGTGGTTGG (BASED ON NMR MODEL OF DEOXYRIBONUCLEIC ACID) REMARK 900 RELATED ID: 1HAP RELATED DB: PDB REMARK 900 COMPLEX OF HUMAN ALPHA-THROMBIN WITH A 15MER OLIGONUCLEOTIDE REMARK 900 GGTTGGTGTGGTTGG (BASED ON X-RAY MODEL OF DEOXYRIBONUCLEIC ACID) REMARK 900 RELATED ID: 1HBT RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH A PEPTIDYL PYRIDINIUM METHYL REMARK 900 KETONE CONTAINING BIVALENT INHIBITOR REMARK 900 RELATED ID: 1HDT RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: ALPHA-THROMBIN; CHAIN: L, H; EC: 3.4.21.5; MOL_ REMARK 900 ID: 2; MOLECULE: HIRUGEN PEPTIDE; CHAIN: P; ENGINEERED: YES; MOL_ID: REMARK 900 3; MOLECULE: N-[N -[N-[4- (AMINOIMINOMETHYL)AMINO]-1-OXOBUTYL]- L - REMARK 900 PHENYLALANYL]-L- ALLO-THREONYL-L- PHENYLALANINE, METHYL ESTER (BMS- REMARK 900 183507); CHAIN: I; ENGINEERED: YES REMARK 900 RELATED ID: 1HGT RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRUGEN REMARK 900 RELATED ID: 1HLT RELATED DB: PDB REMARK 900 ALPHA THROMBIN COMPLEXED WITH THROMBOMODULIN (NONDECAPEPTIDE) AND D- REMARK 900 PHE-PRO-ARG- CHLOROMETHYLKETONE (PPACK) WITH CHLOROMETHYLKETONE REMARK 900 REPLACED BY A METHYLENE GROUP REMARK 900 RELATED ID: 1HUT RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEXED WITH DEOXYRIBONUCLEIC ACID (5'- REMARK 900 D(GPGPTPTPGPGPTPGPTPGPGPTPTPGPG)-3') AND D-PHE-PRO-ARG- REMARK 900 CHLOROMETHYLKETONE (PPACK ) WITH CHLOROMETHYLKETONE REPLACED BY A REMARK 900 METHYLENE GROUP REMARK 900 RELATED ID: 1HXE RELATED DB: PDB REMARK 900 SERINE PROTEASE REMARK 900 RELATED ID: 1HXF RELATED DB: PDB REMARK 900 HUMAN THROMBIN COMPLEX WITH HIRUDIN VARIANT REMARK 900 RELATED ID: 1IHS RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRUTONIN-2 REMARK 900 RELATED ID: 1IHT RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRUTONIN-6 REMARK 900 RELATED ID: 1JMO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HEPARIN COFACTOR II -S195A THROMBINCOMPLEX REMARK 900 RELATED ID: 1JOU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NATIVE S195A THROMBIN WITH ANUNOCCUPIED ACTIVE REMARK 900 SITE REMARK 900 RELATED ID: 1JWT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH A NOVELBICYCLIC REMARK 900 LACTAM INHIBITOR REMARK 900 RELATED ID: 1KTS RELATED DB: PDB REMARK 900 THROMBIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 1KTT RELATED DB: PDB REMARK 900 THROMBIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 1LHC RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO-BOROARG- OH REMARK 900 RELATED ID: 1LHD RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO-BOROLYS- OH REMARK 900 RELATED ID: 1LHE RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO-BORO-N- BUTYL- REMARK 900 AMIDINO-GLYCINE-OH REMARK 900 RELATED ID: 1LHF RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO-BORO- HOMOLYS-OH REMARK 900 RELATED ID: 1LHG RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO- BOROORNITHINE-OH REMARK 900 RELATED ID: 1MH0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ANTICOAGULANT SLOW FORM OF THROMBIN REMARK 900 RELATED ID: 1MU6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH L-378,622 REMARK 900 RELATED ID: 1MU8 RELATED DB: PDB REMARK 900 THROMBIN-HIRUGEN_L-378,650 REMARK 900 RELATED ID: 1MUE RELATED DB: PDB REMARK 900 THROMBIN-HIRUGEN-L405,426 REMARK 900 RELATED ID: 1NM6 RELATED DB: PDB REMARK 900 THROMBIN IN COMPLEX WITH SELECTIVE MACROCYCLIC INHIBITOR AT1.8A REMARK 900 RELATED ID: 1NO9 RELATED DB: PDB REMARK 900 DESIGN OF WEAKLY BASIC THROMBIN INHIBITORS INCORPORATINGNOVEL P1 REMARK 900 BINDING FUNCTIONS: MOLECULAR AND X- RAYCRYSTALLOGRAPHIC STUDIES. REMARK 900 RELATED ID: 1NRN RELATED DB: PDB REMARK 900 ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED PEPTIDE REMARK 900 NRS REMARK 900 RELATED ID: 1NRO RELATED DB: PDB REMARK 900 ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED PEPTIDE REMARK 900 NRP REMARK 900 RELATED ID: 1NRP RELATED DB: PDB REMARK 900 ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED PEPTIDE REMARK 900 NR'S REMARK 900 RELATED ID: 1NRQ RELATED DB: PDB REMARK 900 ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED PEPTIDE REMARK 900 D-FPR'S REMARK 900 RELATED ID: 1NRR RELATED DB: PDB REMARK 900 ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED PEPTIDE REMARK 900 XA AND D-PHE-PRO- ARG CHLOROMETHYLKETONE (PPACK) WITH REMARK 900 CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP REMARK 900 RELATED ID: 1NT1 RELATED DB: PDB REMARK 900 THROMBIN IN COMPLEX WITH SELECTIVE MACROCYCLIC INHIBITOR REMARK 900 RELATED ID: 1NU7 RELATED DB: PDB REMARK 900 STAPHYLOCOAGULASE-THROMBIN COMPLEX REMARK 900 RELATED ID: 1NU9 RELATED DB: PDB REMARK 900 STAPHYLOCOAGULASE-PRETHROMBIN-2 COMPLEX REMARK 900 RELATED ID: 1NY2 RELATED DB: PDB REMARK 900 HUMAN ALPHA THROMBIN INHIBITED BY RPPGF AND HIRUGEN REMARK 900 RELATED ID: 1NZQ RELATED DB: PDB REMARK 900 D-PHE-PRO-ARG-TYPE THROMBIN INHIBITOR REMARK 900 RELATED ID: 1O0D RELATED DB: PDB REMARK 900 HUMAN THROMBIN COMPLEXED WITH A D-PHE-PRO -ARG- TYPEINHIBITOR AND A REMARK 900 C-TERMINAL HIRUDIN DERIVED EXO- SITEINHIBITOR REMARK 900 RELATED ID: 1O2G RELATED DB: PDB REMARK 900 ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING REMARK 900 OF ACTIVE SITE- DIRECTED SERINE PROTEASE INHIBITORS REMARK 900 RELATED ID: 1O5G RELATED DB: PDB REMARK 900 DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTSAT THE REMARK 900 S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190UPA) REMARK 900 RELATED ID: 1OOK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB- ALPHA REMARK 900 AND HUMAN ALPHA- THROMBIN REMARK 900 RELATED ID: 1OYT RELATED DB: PDB REMARK 900 COMPLEX OF RECOMBINANT HUMAN THROMBIN WITH A DESIGNEDFLUORINATED REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1P8V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB- ALPHA REMARK 900 AND ALPHA-THROMBIN AT 2.6A REMARK 900 RELATED ID: 1PPB RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE (PPACK) REMARK 900 WITH CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP REMARK 900 RELATED ID: 1QBV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THROMBIN COMPLEXED WITH AN GUANIDINE- MIMETIC REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1QHR RELATED DB: PDB REMARK 900 NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS REMARK 900 RELATED ID: 1QJ1 RELATED DB: PDB REMARK 900 NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS REMARK 900 RELATED ID: 1QJ6 RELATED DB: PDB REMARK 900 NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS REMARK 900 RELATED ID: 1QJ7 RELATED DB: PDB REMARK 900 NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS REMARK 900 RELATED ID: 1QUR RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN IN COMPLEX WITH BIVALENT, BENZAMIDINE- BASED REMARK 900 SYNTHETIC INHIBITOR REMARK 900 RELATED ID: 1QVH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THROMBIN AND THECENTRAL "E" REMARK 900 REGION OF FIBRIN REMARK 900 RELATED ID: 1RD3 RELATED DB: PDB REMARK 900 2.5A STRUCTURE OF ANTICOAGULANT THROMBIN VARIANT E217K REMARK 900 RELATED ID: 1RIW RELATED DB: PDB REMARK 900 THROMBIN IN COMPLEX WITH NATURAL PRODUCT INHIBITOROSCILLARIN REMARK 900 RELATED ID: 1SB1 RELATED DB: PDB REMARK 900 NOVEL NON-COVALENT THROMBIN INHIBITORS INCORPORATING P1 4, 5,6,7- REMARK 900 TETRAHYDROBENZOTHIAZOLE ARGININE SIDE CHAIN MIMETICS REMARK 900 RELATED ID: 1SFQ RELATED DB: PDB REMARK 900 FAST FORM OF THROMBIN MUTANT R(77A)A BOUND TO PPACK REMARK 900 RELATED ID: 1SG8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PROCOAGULANT FAST FORM OF THROMBIN REMARK 900 RELATED ID: 1SGI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ANTICOAGULANT SLOW FORM OF THROMBIN REMARK 900 RELATED ID: 1SHH RELATED DB: PDB REMARK 900 SLOW FORM OF THROMBIN BOUND WITH PPACK REMARK 900 RELATED ID: 1SL3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTUE OF THROMBIN IN COMPLEX WITH A POTENT P1HETEROCYCLE- REMARK 900 ARYL BASED INHIBITOR REMARK 900 RELATED ID: 1SR5 RELATED DB: PDB REMARK 900 ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEXSTRUCTURE REMARK 900 RELATED ID: 1TA2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH COMPOUND 1 REMARK 900 RELATED ID: 1TA6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH COMPOUND 14B REMARK 900 RELATED ID: 1TB6 RELATED DB: PDB REMARK 900 2.5A CRYSTAL STRUCTURE OF THE ANTITHROMBIN- THROMBIN- REMARK 900 HEPARINTERNARY COMPLEX REMARK 900 RELATED ID: 1TBZ RELATED DB: PDB REMARK 900 HUMAN THROMBIN WITH ACTIVE SITE N-METHYL-D PHENYLALANYL-N- [5- REMARK 900 (AMINOIMINOMETHYL)AMINO]- 1-{{BENZOTHIAZOLYL)CARBONYL] BUTYL]-L- REMARK 900 PROLINAMIDE TRIFLUROACETATE AND EXOSITE-HIRUGEN REMARK 900 RELATED ID: 1THP RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN ALPHA-THROMBIN Y225P MUTANT BOUND TO D- PHE-PRO- REMARK 900 ARG- CHLOROMETHYLKETONE REMARK 900 RELATED ID: 1THR RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRULLIN REMARK 900 RELATED ID: 1THS RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH MDL-28050 REMARK 900 RELATED ID: 1TMB RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRUGEN AND CYCLOTHEONAMIDE A REMARK 900 RELATED ID: 1TMT RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEXED WITH CGP 50,856 (D-PHE-PRO-ARG-PRO -GLY- REMARK 900 GLY-GLY-GLY FOLLOWED BY RESIDUES 53 - 65 OF HIRUDIN, CLEAVED AFTER REMARK 900 ARG I 3) REMARK 900 RELATED ID: 1TMU RELATED DB: PDB REMARK 900 ALPHA-THROMBIN TERNARY COMPLEX WITH HIRUDIN (C-TERMINAL FRAGMENT, REMARK 900 RESIDUES 55 - 65) AND PPACK (D-PHE-PRO-ARG- CHLOROMETHYLKETONE) REMARK 900 RELATED ID: 1TOM RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEXED WITH HIRUGEN REMARK 900 RELATED ID: 1TQ0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE POTENT ANTICOAGULANT THROMBINMUTANT W215A/ REMARK 900 E217A IN FREE FORM REMARK 900 RELATED ID: 1TQ7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ANTICOAGULANT THROMBIN MUTANTW215A/E217A REMARK 900 BOUND TO PPACK REMARK 900 RELATED ID: 1UMA RELATED DB: PDB REMARK 900 ALPHA-THROMBIN (HIRUGEN) COMPLEXED WITH NA-(N,N- DIMETHYLCARBAMOYL)- REMARK 900 ALPHA-AZALYSINE REMARK 900 RELATED ID: 1UVS RELATED DB: PDB REMARK 900 BOVINE THROMBIN--BM51.1011 COMPLEX REMARK 900 RELATED ID: 1VR1 RELATED DB: PDB REMARK 900 SPECIFITY FOR PLASMINOGEN ACTIVATOR INHIBITOR- 1 REMARK 900 RELATED ID: 1WBG RELATED DB: PDB REMARK 900 ACTIVE SITE THROMBIN INHIBITORS REMARK 900 RELATED ID: 2HGT RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRULOG I (CLEAVED BETWEEN ARG 3 AND REMARK 900 PRO 4) REMARK 900 RELATED ID: 2HNT RELATED DB: PDB REMARK 900 GAMMA-THROMBIN REMARK 900 RELATED ID: 2HPP RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH D-PHE-PRO-ARG - CHLOROMETHYLKETONE REMARK 900 (PPACK) CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP AND BOVINE REMARK 900 PROTHROMBIN FRAGMENT 2 REMARK 900 RELATED ID: 2HPQ RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH D-PHE-PRO-ARG - CHLOROMETHYLKETONE REMARK 900 (PPACK) CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP AND HUMAN REMARK 900 PROTHROMBIN FRAGMENT 2 REMARK 900 RELATED ID: 2THF RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN ALPHA-THROMBIN Y225F MUTANT BOUND TO D- PHE-PRO- REMARK 900 ARG- CHLOROMETHYLKETONE REMARK 900 RELATED ID: 4THN RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF ALPHA-THROMBIN- HIRUNORM IV COMPLEX REMARK 900 REVEALS A NOVEL SPECIFICITY SITE RECOGNITION MODE. REMARK 900 RELATED ID: 5GDS RELATED DB: PDB REMARK 900 HIRUNORMS ARE TRUE HIRUDIN MIMETICS. THE CRYSTAL STRUCTURE OF HUMAN REMARK 900 ALPHA-THROMBIN: HIRUNORM V COMPLEX REMARK 900 RELATED ID: 7KME RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN INHIBITED WITH SEL2711. REMARK 900 RELATED ID: 8KME RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN INHIBITED WITH SEL2770. REMARK 900 RELATED ID: 1K21 RELATED DB: PDB REMARK 900 HUMAN THROMBIN-INHIBITOR COMPLEX REMARK 900 RELATED ID: 1K22 RELATED DB: PDB REMARK 900 HUMAN THROMBIN-INHIBITOR COMPLEX REMARK 900 RELATED ID: 1NRS RELATED DB: PDB REMARK 900 ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED PEPTIDE REMARK 900 NRP (CLEAVED, FIRST FOUR RESIDUES ONLY) AND HIRUGEN REMARK 900 RELATED ID: 1VZQ RELATED DB: PDB REMARK 900 COMPLEX OF THROMBIN WITH DESIGNED INHIBITOR 7165 REMARK 900 RELATED ID: 1W7G RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH SULFATED HIRUDIN (RESIDUES 54- 65) AND REMARK 900 L-ARGININE TEMPLATE INHIBITOR CS107 REMARK 900 RELATED ID: 1WAY RELATED DB: PDB REMARK 900 ACTIVE SITE THROMBIN INHIBITORS REMARK 900 RELATED ID: 3HAT RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND FPAM (FIBRINOPEPTIDE A REMARK 900 MIMIC) REMARK 900 RELATED ID: 3HTC RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH RECOMBINANT HIRUDIN (VARIANT 2, LYS 47) REMARK 900 RELATED ID: 4HTC RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH RECOMBINANT HIRUDIN (VARIANT 2, LYS 47) DBREF 1WBG A -3 15 UNP P00734 THRB_HUMAN 328 363 DBREF 1WBG B 16 247 UNP P00734 THRB_HUMAN 364 622 DBREF 1WBG I 55 64 UNP P09945 ITH3_HIRME 62 71 SEQRES 1 A 36 THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO SEQRES 2 A 36 LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG SEQRES 3 A 36 GLU LEU LEU GLU SER TYR ILE ASP GLY ARG SEQRES 1 B 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 B 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 B 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 B 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 B 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 B 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 B 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 B 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 B 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 B 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 B 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 B 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 B 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 B 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 B 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 B 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 B 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 B 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ARG ASP ASP SEQRES 19 B 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 B 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU SEQRES 1 I 10 ASP PHE GLU GLU ILE PRO GLU GLU TYS LEU MODRES 1WBG TYS I 63 TYR O-SULFO-L-TYROSINE HET TYS I 63 16 HET L03 B1248 14 HET DMS B1249 4 HET DMS B1250 4 HET DMS B1251 4 HETNAM TYS O-SULFO-L-TYROSINE HETNAM L03 3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-4H-1,2,4-TRIAZOLE HETNAM DMS DIMETHYL SULFOXIDE FORMUL 3 TYS C9 H11 N O6 S FORMUL 4 L03 C9 H8 CL N3 S FORMUL 5 DMS 3(C2 H6 O S) FORMUL 8 HOH *388(H2 O) HELIX 1 1 PHE A 7 SER A 11 5 5 HELIX 2 2 THR A 14B TYR A 14J 1 9 HELIX 3 3 ALA B 55 CYS B 58 5 4 HELIX 4 4 PRO B 60B ASP B 60E 5 4 HELIX 5 5 THR B 60I ASN B 62 5 3 HELIX 6 6 ASP B 125 LEU B 130 1 9 HELIX 7 7 GLU B 164 SER B 171 1 8 HELIX 8 8 LYS B 185 GLY B 186C 5 5 HELIX 9 9 LEU B 234 GLY B 246 1 13 HELIX 10 10 PRO I 60 LEU I 64 5 5 SHEET 1 BA 7 SER B 20 ASP B 21 0 SHEET 2 BA 7 GLN B 156 PRO B 161 -1 O VAL B 157 N SER B 20 SHEET 3 BA 7 LYS B 135 GLY B 140 -1 O GLY B 136 N LEU B 160 SHEET 4 BA 7 PRO B 198 LYS B 202 -1 O PRO B 198 N THR B 139 SHEET 5 BA 7 TRP B 207 TRP B 215 -1 O TYR B 208 N MET B 201 SHEET 6 BA 7 GLY B 226 HIS B 230 -1 O PHE B 227 N SER B 214 SHEET 7 BA 7 MET B 180 ALA B 183 -1 O PHE B 181 N TYR B 228 SHEET 1 BB 7 GLN B 30 ARG B 35 0 SHEET 2 BB 7 GLU B 39 LEU B 46 -1 O GLU B 39 N ARG B 35 SHEET 3 BB 7 TRP B 51 THR B 54 -1 O LEU B 53 N SER B 45 SHEET 4 BB 7 ALA B 104 LEU B 108 -1 O ALA B 104 N THR B 54 SHEET 5 BB 7 LYS B 81 ILE B 90 -1 N GLU B 86 O LYS B 107 SHEET 6 BB 7 LEU B 64 ILE B 68 -1 O LEU B 64 N LEU B 85 SHEET 7 BB 7 GLN B 30 ARG B 35 -1 O MET B 32 N ARG B 67 SHEET 1 BC 2 LEU B 60 TYR B 60A 0 SHEET 2 BC 2 LYS B 60F ASN B 60G-1 O LYS B 60F N TYR B 60A SSBOND 1 CYS A 1 CYS B 122 1555 1555 2.04 SSBOND 2 CYS B 42 CYS B 58 1555 1555 2.04 SSBOND 3 CYS B 168 CYS B 182 1555 1555 2.00 SSBOND 4 CYS B 191 CYS B 220 1555 1555 2.06 LINK C GLU I 62 N TYS I 63 1555 1555 1.33 LINK C TYS I 63 N LEU I 64 1555 1555 1.33 CISPEP 1 SER B 37 PRO B 37A 0 -3.51 SITE 1 AC1 11 ASP B 189 ALA B 190 GLU B 192 VAL B 213 SITE 2 AC1 11 TRP B 215 GLY B 216 GLY B 219 CYS B 220 SITE 3 AC1 11 GLY B 226 PHE B 227 HOH B2322 SITE 1 AC2 3 ASN B 98 ILE B 174 TRP B 215 SITE 1 AC3 5 LEU B 130 ILE B 162 ARG B 165 PHE B 181 SITE 2 AC3 5 HOH B2323 SITE 1 AC4 6 GLU B 127 SER B 129B SER B 171 PHE B 204A SITE 2 AC4 6 GLY B 223 LYS B 224 SITE 1 AC5 22 PHE B 34 GLN B 38 LEU B 40 LEU B 65 SITE 2 AC5 22 ARG B 67 ARG B 73 THR B 74 ARG B 75 SITE 3 AC5 22 TYR B 76 LYS B 81 ILE B 82 MET B 84 SITE 4 AC5 22 GLN B 151 SER B 153 HOH B2072 HOH B2141 SITE 5 AC5 22 HOH I2004 HOH I2005 HOH I2006 HOH I2008 SITE 6 AC5 22 HOH I2009 HOH I2010 CRYST1 69.392 71.785 71.733 90.00 99.87 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014411 0.000000 0.002507 0.00000 SCALE2 0.000000 0.013930 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014150 0.00000 MASTER 912 0 5 10 16 0 14 6 0 0 0 24 END